受强制性开放获取政策约束的文章 - Kaleb Yohay了解详情
可在其他位置公开访问的文章：23 篇
Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation
E Legius, L Messiaen, P Wolkenstein, P Pancza, RA Avery, Y Berman, ...
Genetics in Medicine 23 (8), 1506-1513, 2021
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK …
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation
SR Plotkin, L Messiaen, E Legius, P Pancza, RA Avery, JO Blakeley, ...
Genetics in Medicine 24 (9), 1967-1977, 2022
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK …
Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in …
M Koczkowska, T Callens, Y Chen, A Gomes, AD Hicks, A Sharp, E Johns, ...
Human mutation 41 (1), 299-315, 2020
强制性开放获取政策： US National Institutes of Health, Government of Italy, Children's Tumor …
Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study
M Nickel, A Simonati, D Jacoby, S Lezius, D Kilian, B Van de Graaf, ...
The Lancet Child & Adolescent Health 2 (8), 582-590, 2018
强制性开放获取政策： US National Institutes of Health, European Commission, Federal Ministry of …
Long-term expression and safety of administration of AAVrh. 10hCLN2 to the brain of rats and nonhuman primates for the treatment of late infantile neuronal ceroid lipofuscinosis
D Sondhi, L Johnson, K Purpura, S Monette, MM Souweidane, MG Kaplitt, ...
Human Gene Therapy, Part B: Methods 23 (5), 324-335, 2012
强制性开放获取政策： US National Institutes of Health
Management of neurofibromatosis type 1-associated plexiform neurofibromas
MJ Fisher, JO Blakeley, BD Weiss, E Dombi, S Ahlawat, S Akshintala, ...
Neuro-oncology 24 (11), 1827-1844, 2022
强制性开放获取政策： US National Institutes of Health
Consensus recommendations to accelerate clinical trials for neurofibromatosis type 2
DG Evans, M Kalamarides, K Hunter-Schaedle, J Blakeley, J Allen, ...
Clinical cancer research 15 (16), 5032-5039, 2009
强制性开放获取政策： US National Institutes of Health
The use of MEK inhibitors in neurofibromatosis type 1–associated tumors and management of toxicities
LJ Klesse, JT Jordan, HB Radtke, T Rosser, E Schorry, N Ullrich, ...
The Oncologist 25 (7), e1109-e1116, 2020
强制性开放获取政策： US National Institutes of Health
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus
PMK De Blank, AM Gross, S Akshintala, JO Blakeley, G Bollag, A Cannon, ...
Neuro-oncology 24 (11), 1845-1856, 2022
强制性开放获取政策： US National Institutes of Health, Cancer Research UK, Brain Tumour Charity, UK
Slowing late infantile Batten disease by direct brain parenchymal administration of a rh.10 adeno-associated virus expressing CLN2
D Sondhi, SM Kaminsky, NR Hackett, OE Pagovich, JB Rosenberg, ...
Science translational medicine 12 (572), eabb5413, 2020
强制性开放获取政策： US National Institutes of Health
Spectrum of ocular manifestations in CLN2-associated batten (Jansky-Bielschowsky) disease correlate with advancing age and deteriorating neurological function
A Orlin, D Sondhi, MT Witmer, MM Wessel, JG Mezey, SM Kaminsky, ...
PLoS One 8 (8), e73128, 2013
强制性开放获取政策： US National Institutes of Health
The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas
S Jackson, EH Baker, AM Gross, P Whitcomb, A Baldwin, J Derdak, ...
Neuro-Oncology Advances 2 (1), vdaa095, 2020
强制性开放获取政策： US National Institutes of Health
Brain region–specific degeneration with disease progression in late infantile neuronal ceroid lipofuscinosis (CLN2 disease)
JP Dyke, D Sondhi, HU Voss, K Yohay, C Hollmann, D Mancenido, ...
American Journal of Neuroradiology 37 (6), 1160-1169, 2016
强制性开放获取政策： US National Institutes of Health
Efficacy of local polymer-based and systemic delivery of the anti-glutamatergic agents riluzole and memantine in rat glioma models
K Yohay, B Tyler, KD Weaver, AC Pardo, D Gincel, J Blakeley, H Brem, ...
Journal of neurosurgery 120 (4), 854-863, 2014
强制性开放获取政策： US National Institutes of Health
Accuracy of reported community diagnosis of autism spectrum disorder
M Hausman-Kedem, BE Kosofsky, G Ross, K Yohay, E Forrest, ...
Journal of psychopathology and behavioral assessment 40, 367-375, 2018
强制性开放获取政策： US National Institutes of Health
Assessment of disease severity in late infantile neuronal ceroid lipofuscinosis using multiparametric MR imaging
JP Dyke, D Sondhi, HU Voss, DC Shungu, X Mao, K Yohay, S Worgall, ...
American Journal of Neuroradiology 34 (4), 884-889, 2013
强制性开放获取政策： US National Institutes of Health
Comparison of hybrid 18F. fluorodeoxyglucose positron emission tomography/magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of …
RA Raad, S Lala, JC Allen, J Babb, CW Mitchell, AM Franceschi, K Yohay, ...
World Journal of Nuclear Medicine 17 (04), 241-248, 2018
强制性开放获取政策： US National Institutes of Health
Ophthalmic artery ischemic syndrome associated with neurofibromatosis and moyamoya syndrome
MT Witmer, R Levy, K Yohay, S Kiss
JAMA ophthalmology 131 (4), 538-539, 2013
强制性开放获取政策： Swiss National Science Foundation
Creation of an international registry to support discovery in schwannomatosis
KL Ostrow, AL Bergner, J Blakeley, DG Evans, R Ferner, JM Friedman, ...
American Journal of Medical Genetics Part A 173 (2), 407-413, 2017
强制性开放获取政策： National Institute for Health Research, UK, Children's Tumor Foundation, USA
Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis
T González-Muñoz, A Di Giannatale, S García-Silva, V Santos, ...
Clinical Cancer Research 29 (18), 3744-3758, 2023
强制性开放获取政策： US Department of Defense, European Commission, Government of Spain
出版信息和资助信息由计算机程序自动确定